Multifunctional Nanofibrous Hollow Microspheres for Enhanced Periodontal Bone Regeneration.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Li Q;Li Q;Li Q; Ma C; Ma C; Ma C; Ma C; Jing Y; Jing Y; Liu X; Liu X; Liu X
  • Source:
    Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jul; Vol. 11 (28), pp. e2402335. Date of Electronic Publication: 2024 May 17.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
    • Publication Information:
      Original Publication: Weinheim : WILEY-VCH, [2014]-
    • Subject Terms:
    • Abstract:
      Destructive periodontitis destroys alveolar bone and eventually leads to tooth loss. While guided bone regeneration, which is based on creating a physical barrier to hinder the infiltration of epithelial and connective tissues into defect sites, has been widely used for alveolar bone regeneration, its outcomes remain variable. In this work, a multifunctional nanofibrous hollow microsphere (NFHMS) is developed for enhanced alveolar bone regeneration. The NFHMS is first prepared via combining a double emulsification and a thermally induced phase separation process. Next, E7, a short peptide with high specific affinity to bone marrow-derived stem cells (BMSCs), is conjugated onto the surface of NFHMS. After that, bone forming peptide (BFP), a short peptide derived from bone morphology protein 7 is loaded in calcium phosphate (CaP) nanoparticles, which are further encapsulated in the hollow space of the NFHMS-E7 to form NFHMS-E7-CaP/BFP. The NFHMS-E7-CaP/BFP selectively promoted the adhesion of BMSCs and expelled the adhesion of fibroblasts and epithelial cells. In addition, the BFP is sustainedly released from the NFHMS-E7-CaP/BFP to enhance the osteogenesis of BMSCs. A rat challenging fenestration defect model showed that the NFHMS-E7-CaP/BFP significantly enhanced alveolar bone tissue regeneration. This work provides a novel bioengineering approach for guided bone regeneration.
      (© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbH.)
    • References:
      J Biomed Mater Res A. 2012 Nov;100(11):3029-41. (PMID: 22707234)
      ACS Appl Mater Interfaces. 2018 Jan 24;10(3):2377-2390. (PMID: 29280610)
      Mol Med Rep. 2019 May;19(5):3807-3814. (PMID: 30896834)
      J Biomed Mater Res A. 2015 Jan;103(1):318-29. (PMID: 24659568)
      Clin Oral Implants Res. 2010 Jun;21(6):567-76. (PMID: 20666785)
      J Clin Periodontol. 1991 Jul;18(6):494-8. (PMID: 1890234)
      J Mater Chem B. 2018 Jan 7;6(1):165-173. (PMID: 32254204)
      Adv Sci (Weinh). 2024 Jul;11(28):e2402335. (PMID: 38757666)
      J Colloid Interface Sci. 2019 Mar 15;539:468-480. (PMID: 30611042)
      J Biomed Mater Res B Appl Biomater. 2022 Sep;110(9):2157-2182. (PMID: 35322931)
      Mater Sci Eng R Rep. 2017 Jan;111:1-26. (PMID: 28649171)
      Exp Mol Med. 2017 May 12;49(5):e328. (PMID: 28496198)
      Nat Commun. 2019 Aug 6;10(1):3523. (PMID: 31388014)
      Int J Periodontics Restorative Dent. 1994 Apr;14(2):166-80. (PMID: 7928132)
      Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:562-568. (PMID: 28183645)
      ACS Appl Mater Interfaces. 2019 Mar 6;11(9):8878-8895. (PMID: 30777748)
      Biomaterials. 2019 Dec;223:119458. (PMID: 31491598)
      Adv Drug Deliv Rev. 2003 Nov 28;55(12):1613-29. (PMID: 14623404)
      Bioact Mater. 2020 Feb 28;5(2):297-308. (PMID: 32154444)
      Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001724. (PMID: 16625546)
      J Periodontol. 2002 Jan;73(1):63-72. (PMID: 11852905)
      Biomaterials. 2012 Apr;33(12):3375-87. (PMID: 22322196)
      Biotechnol J. 2017 Dec;12(12):. (PMID: 28862380)
      Biomaterials. 2022 Nov;290:121819. (PMID: 36209579)
      J Am Dent Assoc. 2018 Jul;149(7):576-588.e6. (PMID: 29957185)
      Carbohydr Polym. 2022 Sep 15;292:119693. (PMID: 35725181)
      Appl Mater Today. 2018 Mar;10:194-202. (PMID: 29577064)
      Dent Clin North Am. 2022 Oct;66(4):659-672. (PMID: 36216452)
      Bioact Mater. 2022 Aug 09;25:485-499. (PMID: 37056261)
      Biomaterials. 2012 Oct;33(29):7057-63. (PMID: 22795855)
      Stem Cell Res. 2018 Jan;26:28-35. (PMID: 29202447)
      Biomaterials. 2008 Oct;29(28):3815-21. (PMID: 18617260)
      ACS Biomater Sci Eng. 2020 Sep 14;6(9):5202-5214. (PMID: 33455270)
      Am J Transl Res. 2018 Aug 15;10(8):2480-2490. (PMID: 30210686)
      Tissue Eng Part A. 2013 Aug;19(15-16):1754-63. (PMID: 23469769)
      Periodontol 2000. 2016 Jun;71(1):128-39. (PMID: 27045434)
      Prog Polym Sci. 2016 Feb 1;53:86-168. (PMID: 27022202)
      ACS Appl Mater Interfaces. 2022 Sep 28;14(38):42904-42914. (PMID: 36102571)
      Tissue Eng Part B Rev. 2016 Aug;22(4):284-97. (PMID: 26857241)
    • Grant Information:
      R01 DE029808 United States DE NIDCR NIH HHS; R01 DE032540 United States DE NIDCR NIH HHS; DE032540 United States DE NIDCR NIH HHS; DE029808 United States DE NIDCR NIH HHS
    • Contributed Indexing:
      Keywords: alveolar bone regeneration; injectable; microspheres; nanofibers; periodontitis
    • Accession Number:
      0 (Calcium Phosphates)
      97Z1WI3NDX (calcium phosphate)
    • Publication Date:
      Date Created: 20240517 Date Completed: 20240724 Latest Revision: 20240726
    • Publication Date:
      20240726
    • Accession Number:
      PMC11267322
    • Accession Number:
      10.1002/advs.202402335
    • Accession Number:
      38757666